Zacks Investment Management’s Lyell Immunopharma LYEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-706	Closed	-$31.5K	–	683
2024 Q1	$31.5K	Buy	+706	New	+$31.5K	﹤0.01%	628
2023 Q2	–	Sell	-542	Closed	-$25.6K	–	691
2023 Q1	$25.6K	Hold	542	–	–	﹤0.01%	620
2022 Q4	$37.6K	Buy	+542	New	+$37.6K	﹤0.01%	588